This 9-month study is evaluating whether a new, more stable formulation of an investigational dengue vaccine, containing the same active ingredients as the version approved overseas, provides comparable immune protection and safety.
This study is being conducted at our Central Coast and Western Sydney clinics.
To assess the safety, tolerability and immunogenicity of an investigational shingles vaccine (Zoster-1018) compared to Shingrix, an approved shingles vaccine, in adults aged 70 years and older.
The study is being conducted at our Brisbane and Central Coast clinics.
This clinical trial is assessing whether an investigational vaccine can safely and effectively prevent chlamydia infections among young adults.
The study is being conducted at our Brisbane and Canberra clinics.
This study is testing a new investigational influenza vaccine to find the safest and most effective dose for better prevention of influenza outbreaks. Recruiting ages 18+.
The study is being conducted at our Brisbane and Canberra clinics.
